Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel for atopic dermatitis and asthma prevention in infants
NCT00124709Phase 4Terminated
- Sponsor
- Novartis
- Start
- Oct 2003
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), asthma, sponsored by Novartis. Started Oct 2003; status: terminated.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)asthma
Beyond the preview
Go deeper on NCT00124709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124709.